Rheumatoid Arthritis Health Center

109 50
Rheumatoid Arthritis Health Center

Tools & Resources



NewsRelated to Rheumatoid Arthritis

  1. Arthritis Treatments Raise Shingles Risk

    Feb. 17, 2009 -- Some of the powerful new drugs that offer relief to rheumatoid arthritis sufferers may increase risk of a different kind of suffering: shingles. Members of a class of drugs called TNF-alpha blockers nearly doubled the risk of herpes zoster, better known as shingles, among rheumatoid
    Read Full Article
  2. Rheumatoid Arthritis Tougher on Women?

    Jan. 14, 2009 -- Rheumatoid arthritis may not only be more common in women than men, it may also take a tougher toll on women, a new study shows. The study, published online in Arthritis Research & Therapy, included about 6,000 patients in 25 countries, including the U.S. The patients completed surv
    Read Full Article
  3. RA Diagnosis Doubles Heart Attack Odds

    Oct. 30, 2008 -- Getting a diagnosis of rheumatoid arthritis doubles the risk of having a heart attack within the next 10 years, according to Swedish researchers presenting their findings this week at the annual meeting of the American College of Rheumatology in San Francisco. But that disturbing ne
    Read Full Article
  4. Rheumatoid Arthritis May Be Up in Women

    Oct. 27, 2008 -- Rheumatoid arthritis appears to be increasing among women, but not men, after 40 years of decline, according to Mayo Clinic researchers. "We don't know why," says Hilal Maradit-Kremers, MD, associate professor of epidemiology at the Mayo Clinic in Rochester, Minn., who is presenting
    Read Full Article
  5. Quit Smoking to Ease Rheumatoid Arthritis

    Oct. 25, 2008 -- People with rheumatoid arthritis may be able to reduce the pain, stiffness, and other symptoms of their disease by quitting smoking, new research indicates. Scientists presented evidence Saturday at the American College of Rheumatology Annual Scientific Meeting in San Francisco that
    Read Full Article
  6. Drug Combo Fights Rheumatoid Arthritis

    July 15, 2008 -- In the early stages of rheumatoid arthritis, taking the drugs Enbrel and methotrexate may make remission more likely than taking methotrexate alone, a new study shows. The study, published in The Lancet, included 542 rheumatoid arthritis patients in Europe, Latin America, Asia, and
    Read Full Article
  7. FDA Checking for Cancer-TNF Drug Link

    June 4, 2008 -- The FDA is investigating whether cancers in about 30 children and young adults are linked to the use of Remicade, Enbrel, Humira, or Cimzia to treat childhood arthritis, Crohn's, or other diseases. The cancers occurred over a 10-year period beginning in 1998. Remicade is approved for
    Read Full Article
  8. Antsy Rheumatoid Arthritis Antidote?

    April 24, 2008 -- Will rheumatoid arthritis and hepatitis meet their match in a certain type of Chinese ant? The Chinese ant Polyrhacis lamellidens has painkilling and anti-inflammatory properties and is used in Chinese folk medicine to treat rheumatoid arthritis and hepatitis, Chinese and Japanese
    Read Full Article
  9. FDA OKs Orencia for Juvenile Arthritis

    April 10, 2008 -- Children ages 6 and older living with a moderate to severe form of juvenile rheumatoid arthritis (JRA) have a new treatment option. The FDA approved the drug Orencia for pediatric patients after a large study showed that those who received the medication had significantly fewer sym
    Read Full Article
  10. RA Heart Tip: Try Gluten-Free Vegan Diet

    March 21, 2008 -- "Gluten-free" vegan diets aren't just for health-food nuts. New research from Sweden shows that rheumatoid arthritis (RA) patients who skip both animal products and certain grains could reduce their risk of having a heart attack or stroke. RA is a chronic inflammatory disease that
    Read Full Article

Displaying 81 - 90of 180 Articles<<Prev Page56789 1011121314Next>>
Subscribe to our newsletter
Sign up here to get the latest news, updates and special offers delivered directly to your inbox.
You can unsubscribe at any time

Leave A Reply

Your email address will not be published.